“…This imaging marker likely reflects active bleeding, is more commonly detected in patients with impaired hemostatic function, 23,24 and is strongly associated with hematoma expansion. 19,20 From a clinical and therapeutic perspective, hematoma volume on admission and ICH expansion are potentially modifiable determinants of ICH outcome 2,25 and, therefore, represent appealing targets for several ICH therapeutic strategies. 26,27 Given the influence of serum calcium level on ICH volume and expansion, there may be a therapeutic opportunity.…”